Have a personal or library account? Click to login
The correlation between Body Mass Index and histological features of Nonalcoholic Fatty Liver Disease Cover

The correlation between Body Mass Index and histological features of Nonalcoholic Fatty Liver Disease

Romanian Journal of Internal Medicine
Volume 61 (2023): Issue 3 (September 2023)
By: Ana Calin-Necula,  Vlad Enciu,  Priscila Ologeanu,  Alexandru Constantin Moldoveanu and  Carmen Fierbinteanu Braticevici  
Open Access
|May 2023

References

  1. YOUNOSSI; KOENIG; ABDELATIF; FAZEL; HENRY; WYMER. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016, 64, 73–84, doi:10.1002/hep.28431.
    Search in Google ScholarBack to article
  2. CHRYSAVGIS; ZTRIVA; PROTOPAPAS; TZIOMALOS; CHOLONGITAS. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World J Gastroenterol 2020, 26, 6514–6528, doi:10.3748/wjg.v26.i42.6514.
    Search in Google ScholarBack to article
  3. NEWSOME; SCHATTENBERG; SERFATY; AGHEMO; AUGUSTIN; TSOCHATZIS; et al. The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries. Digestive and Liver Disease 2020, 52, e33–e34, doi:10.1016/j.dld.2019.12.121.
    Search in Google ScholarBack to article
  4. YOUNOSSI; TAMPI; RACILA; QIU; BURNS; YOUNOSSI; et al. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. Diabetes Care 2020, 43, 283–289, doi: 10.2337/dc19-1113.
    Open DOISearch in Google ScholarBack to article
  5. GASTALDELLI; CUSI. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Rep 2019, 1, 312–328, doi: 10.1016/j.jhepr.2019.07.002.
    Open DOISearch in Google ScholarBack to article
  6. BRUNT; KLEINER; CARPENTER; RINELLA; HARRISON; LOOMBA; et al. NAFLD: Reporting Histologic Findings in Clinical Practice. Hepatology 2021, 73, 2028–2038, doi: 10.1002/hep.31599.
    Open DOISearch in Google ScholarBack to article
  7. CUSI. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2009, 16, 141–149, doi: 10.1097/MED.0b013e3283293015.
    Open DOISearch in Google ScholarBack to article
  8. HILLENBRAND; KIEBLER; SCHWAB; SCHEJA; XU; HENNE-BRUNS; et al. Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors. BMC Res Notes 2015, 8, 290, doi: 10.1186/s13104-015-1224-7.
    Open DOISearch in Google ScholarBack to article
  9. MACHADO; MARQUES-VIDAL; CORTEZ-PINTO. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 2006, 45, 600–606, doi: 10.1016/j.jhep.2006.06.013.
    Open DOISearch in Google ScholarBack to article
  10. WONG; CHAN; CHITTURI; CHAWLA; DAN; DUSEJA; et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017–Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2018, 33, 70–85, doi: 10.1111/jgh.13857.
    Open DOISearch in Google ScholarBack to article
  11. CHALASANI; YOUNOSSI; LAVINE; CHARLTON; CUSI; RINELLA; et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018, 67, 328–357, doi: 10.1002/hep.29367.
    Open DOISearch in Google ScholarBack to article
  12. LOOMIS; KABADI; PREISS; HYDE; BONATO; ST LOUIS; et al. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. J Clin Endocrinol Metab 2016, 101, 945–952, doi: 10.1210/jc.2015-3444.
    Open DOISearch in Google ScholarBack to article
  13. YOUNOSSI; GOLABI; DE AVILA; PAIK; SRISHORD; FUKUI; et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol 2019, 71, 793–801, doi: 10.1016/j.jhep.2019.06.021.
    Open DOISearch in Google ScholarBack to article
  14. ANGULO; KEACH; BATTS; LINDOR. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30, 1356–1362, doi: 10.1002/hep.510300604.
    Open DOISearch in Google ScholarBack to article
  15. DIXON; BHATHAL; O'BRIEN. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121, 91–100, doi: 10.1053/gast.2001.25540.
    Open DOISearch in Google ScholarBack to article
  16. EGUCHI; HYOGO; ONO; MIZUTA; ONO; FUJIMOTO; et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012, 47, 586–595, doi: 10.1007/s00535-012-0533-z.
    Open DOISearch in Google ScholarBack to article
  17. HAGSTROM; NASR; EKSTEDT; STAL; HULTCRANTZ; KECHAGIAS. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2019, 17, 1148–1156 e1144, doi: 10.1016/j.cgh.2018.11.030.
    Open DOISearch in Google ScholarBack to article
  18. GHAEMI; HOSSEINI; OSATI; NAGHIZADEH; DEHGHAN; EHRAMPOUSH; et al. Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease. Sci Rep 2018, 8, 4788, doi: 10.1038/s41598-018-23192-x.
    Open DOISearch in Google ScholarBack to article
  19. HUANG; GREENSON; CHAO; ANDERSON; PETERMAN; JACOBSON; et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005, 100, 1072–1081, doi: 10.1111/j.1572-0241.2005.41334.x.
    Open DOISearch in Google ScholarBack to article
  20. HAMAGUCHI; KOJIMA; TAKEDA; NAKAGAWA; TANIGUCHI; FUJII; et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143, 722–728, doi: 10.7326/0003-4819-143-10-200511150-00009.
    Open DOISearch in Google ScholarBack to article
  21. BHATIA; CURZEN; CALDER; BYRNE. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012, 33, 1190–1200, doi: 10.1093/eurheartj/ehr453.
    Open DOISearch in Google ScholarBack to article
  22. PROMRAT; KLEINER; NIEMEIER; JACKVONY; KEARNS; WANDS; et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51, 121–129, doi: 10.1002/hep.23276.
    Open DOISearch in Google ScholarBack to article
  23. BRIL; BARB; PORTILLO-SANCHEZ; BIERNACKI; LOMONACO; SUMAN; et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 2017, 65, 1132–1144, doi: 10.1002/hep.28985.
    Open DOISearch in Google ScholarBack to article
  24. SEO. Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61–9). J Obes Metab Syndr 2022, 31, 350–351, doi: 10.7570/jomes22049.
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/rjim-2023-0011 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 147 - 153
Submitted on: Apr 23, 2023
Published on: May 6, 2023
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Non-alcoholic Fatty Liver Disease,
Body Mass Index,
Weist circumference,
Liver biopsy,
Inflammatory activity,
Steatosis,
Fibrosis
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2023 Ana Calin-Necula, Vlad Enciu, Priscila Ologeanu, Alexandru Constantin Moldoveanu, Carmen Fierbinteanu Braticevici, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 61 (2023): Issue 3 (September 2023)Next article